Diversified Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $5.04M | Sell |
33,796
-21,838
| -39% | -$3.06M | 0.11% | 115 |
|
|
2026
Q2 | $7.03M | Buy |
55,634
+15,148
| +37% | +$2M | 0.11% | 100 |
|
|
2026
Q1 | $5.64M | Sell |
40,486
-6,384
| -14% | -$894K | 0.1% | 111 |
|
|
2025
Q4 | $5.75M | Buy |
46,870
+3,641
| +8% | +$442K | 0.11% | 112 |
|
|
2025
Q3 | $4.8M | Buy |
43,229
+8,422
| +24% | +$957K | 0.1% | 117 |
|
|
2025
Q2 | $3.86M | Sell |
34,807
-31
| -0.1% | -$3.3K | 0.09% | 131 |
|
|
2025
Q1 | $3.9M | Buy |
34,838
+383
| +1% | +$39.5K | 0.1% | 123 |
|
|
2024
Q4 | $3.18M | Buy |
34,455
+1,019
| +3% | +$91.7K | 0.08% | 151 |
|
|
2024
Q3 | $2.8M | Buy |
33,436
+449
| +1% | +$34.3K | 0.07% | 169 |
|
|
2024
Q2 | $2.26M | Buy |
32,987
+3,483
| +12% | +$232K | 0.06% | 182 |
|
|
2024
Q1 | $2.16M | Sell |
29,504
-3,201
| -10% | -$246K | 0.07% | 177 |
|
|
2023
Q4 | $2.65M | Sell |
32,705
-4,860
| -13% | -$378K | 0.09% | 127 |
|
|
2023
Q3 | $2.82M | Sell |
37,565
-5,393
| -13% | -$415K | 0.11% | 109 |
|
|
2023
Q2 | $3.31M | Sell |
42,958
-105
| -0.2% | -$8.37K | 0.12% | 100 |
|
|
2023
Q1 | $3.57M | Buy |
43,063
+1,763
| +4% | +$146K | 0.14% | 90 |
|
|
2022
Q4 | $3.55M | Buy |
41,300
+5,992
| +17% | +$475K | 0.15% | 84 |
|
|
2022
Q3 | $2.18M | Buy |
35,308
+632
| +2% | +$39.9K | 0.1% | 106 |
|
|
2022
Q2 | $2.14M | Sell |
34,676
-853
| -2% | -$52.8K | 0.09% | 122 |
|
|
2022
Q1 | $2.11M | Buy |
35,529
+1,982
| +6% | +$127K | 0.07% | 137 |
|
|
2021
Q4 | $2.44M | Buy |
33,547
+2,723
| +9% | +$188K | 0.08% | 127 |
|
|
2021
Q3 | $2.15M | Sell |
30,824
-2,209
| -7% | -$155K | 0.08% | 132 |
|
|
2021
Q2 | $2.28M | Buy |
33,033
+1,311
| +4% | +$87.5K | 0.08% | 123 |
|
|
2021
Q1 | $2.05M | Sell |
31,722
-1,161
| -4% | -$74.9K | 0.08% | 126 |
|
|
2020
Q4 | $1.92M | Sell |
32,883
-628
| -2% | -$37.9K | 0.08% | 126 |
|
|
2020
Q3 | $2.12M | Buy |
33,511
+3,684
| +12% | +$255K | 0.1% | 113 |
|
|
2020
Q2 | $2.3M | Buy |
29,827
+32
| +0.1% | +$2.45K | 0.12% | 93 |
|
|
2020
Q1 | $2.23M | Buy |
29,795
+591
| +2% | +$40.8K | 0.13% | 86 |
|
|
2019
Q4 | $1.9M | Buy |
29,204
+7,282
| +33% | +$474K | 0.09% | 98 |
|
|
2019
Q3 | $1.39M | Sell |
21,922
-2,115
| -9% | -$138K | 0.07% | 101 |
|
|
2019
Q2 | $1.62M | Sell |
24,037
-128
| -0.5% | -$8.42K | 0.08% | 93 |
|
|
2019
Q1 | $1.57M | Buy |
24,165
+1,031
| +4% | +$68.5K | 0.08% | 92 |
|
|
2018
Q4 | $1.45M | Buy |
+23,134
| New | +$1.62M | 0.08% | 89 |
|
Other funds holding GILD
Diversified Trust's GILD Position: Q3 2026 in Review
Diversified Trust reduced its Gilead Sciences (GILD) stake by 39% in Q3 2026, selling an estimated $3.06M and leaving 33,796 shares worth $5.04M. The position accounts for 0.11% of the portfolio, ranked #115.
Diversified Trust first reported a position in GILD in Q4 2018 and has held it in 32 quarters since. The position peaked at $7.03M in Q2 2026. 2,308 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Diversified Trust held 33,796 shares of Gilead Sciences worth $5.04M as of Q3 2026.
- Diversified Trust sold 21,838 Gilead Sciences shares in Q3 2026, an estimated $3.06M.
- Gilead Sciences made up 0.11% of Diversified Trust's portfolio in Q3 2026, its #115 holding.
- Diversified Trust first reported a position in Gilead Sciences in Q4 2018 and has held it in 32 quarters since.
- Diversified Trust's Gilead Sciences position peaked at $7.03M in Q2 2026.
- 2,308 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.